Massachusetts General Hospital

SAN ANTONIO — Patients with breast cancer who achieved pathologic complete response to neoadjuvant chemotherapy attained similar survival outcomes regardless of whether they underwent adjuvant chemotherapy, according to results of a comprehensive patient-level meta-analysis presented at San Antonio Breast Cancer Symposium.

A decade ago, patients with newly diagnosed multiple myeloma typically survived 3 to 5 years.

SAN DIEGO — Bexagliflozin was effective and well-tolerated in lowering hemoglobin A1c in patients with diabetes and stage 3a/3b CKD, according to study results presented at ASN Kidney Week.

SAN DIEGO — The 2018 Homer W. Smith Award was presented to M. Amin Arnaout, MD, professor of medicine at Harvard Medical School and physician at Massachusetts General Hospital, today at ASN Kidney Week 2018.

Single IV ketamine doses of 0.5 mg/kg and 1 mg/kg were more effective than an active placebo in reducing symptoms over a 3-day period in patients with treatment-resistant depression, according to study data.

Adults with obesity who underwent Roux-en-Y gastric bypass experienced high-turnover bone loss and bone microarchitectural deterioration that persisted 5 years after the procedure, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

American Society for Radiation Oncology designated 35 members as ASTRO fellows.

A review of clinical research published in Harvard Review of Psychiatry found that depression and anxiety disorders remain underrecognized in patients with heart failure and may lead to adverse outcomes.

The use of benzodiazepines was linked to a fivefold increase in the risk for opioid-related overdose during the first 90 days of such treatment, according to findings recently published in JAMA Network Open.

CHICAGO — Keith T. Flaherty, MD, medical oncologist at Massachusetts General Hospital Cancer Center, spoke with HemOnc Today at ASCO Annual Meeting about results from the COLUMBUS trial.